Care Coordination in a SARS-CoV-2-infected Child With Newly Diagnosed Medulloblastoma and Fanconi Anemia

J Pediatr Hematol Oncol. 2021 Oct 1;43(7):e972-e974. doi: 10.1097/MPH.0000000000002021.

Abstract

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is responsible for a global pandemic that can cause severe infections in children, especially those with comorbid conditions. Here, we report a case of a child with a newly diagnosed medulloblastoma, Fanconi Anemia, and SARS-CoV-2 infection. Through multidisciplinary care coordination and meticulous planning, we were able to safely initiate this patient's oncology care and implement a long-term model to address the patient's care. This approach could be replicated with any newly diagnosed pediatric patient that requires monitoring for signs of COVID-19 with concurrent oncology care.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • COVID-19 / complications*
  • COVID-19 / transmission
  • COVID-19 / virology
  • Child, Preschool
  • Fanconi Anemia / diagnosis
  • Fanconi Anemia / drug therapy*
  • Fanconi Anemia / virology
  • Female
  • Humans
  • Medulloblastoma / diagnosis
  • Medulloblastoma / drug therapy*
  • Medulloblastoma / virology
  • Prognosis
  • SARS-CoV-2 / isolation & purification*